Top-News
Biotechnologie USA

Dynavax Technologies News

Aktie
WKN:  A12EV9 ISIN:  US2681582019 US-Symbol:  DVAX
11,015 €
+0,24 €
+2,23%
03.05.24 18:49:05
Handeln Depot/Watchlist
Aktienanzahl *
128,47 Mio.
Marktkapitalisierung *
1,40 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 02.08.2023

Dynavax Technologies News

09.02.23 - PR Newswire
Dynavax to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023
Dynavax to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023 PR Newswire
31.01.23 - PR Newswire
Dynavax Announces Uplisting to the Nasdaq Global Select Market
Dynavax Announces Uplisting to the Nasdaq Global Select Market PR Newswire
09.01.23 - PR Newswire
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Highlights and Phase 1 Shingles Topline Results
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Highlights and Phase 1 Shingles Topline Results PR Newswire
12.12.22 - Der Aktionär
Impfstoff‑Aktien: Chinas Ausweg?
09.11.22 - PR Newswire
Dynavax to Present at Two Upcoming Investor Conferences
Dynavax to Present at Two Upcoming Investor Conferences PR Newswire
03.11.22 - PR Newswire
Dynavax Reports Third Quarter 2022 Financial Results
Dynavax Reports Third Quarter 2022 Financial Results PR Newswire
20.10.22 - PR Newswire
Dynavax to Report Third Quarter Financial Results and Host Conference Call on November 3, 2022
Dynavax to Report Third Quarter Financial Results and Host Conference Call on November 3, 2022 PR Newswire
14.10.22 - PR Newswire
Dynavax to Present at the H.C. Wainwright 3rd Annual Hepatitis B Virus Virtual Conference
Dynavax to Present at the H.C. Wainwright 3rd Annual Hepatitis B Virus Virtual Conference PR Newswire
12.09.22 - PR Newswire
Dynavax Announces First Participant Dosed in a Phase 2 Clinical Trial Evaluating an Adjuvanted Plague Vaccine
Dynavax Announces First Participant Dosed in a Phase 2 Clinical Trial Evaluating an Adjuvanted Plague Vaccine PR Newswire
08.09.22 - PR Newswire
Dynavax to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Dynavax to Present at the H.C. Wainwright 24th Annual Global Investment Conference PR Newswire
05.08.22 - PR Newswire
Thinking about buying stock in AN2 Therapeutics, AMTD IDEA Group, Dynavax Technologies, Yelp, or Honest Company?
Thinking about buying stock in AN2 Therapeutics, AMTD IDEA Group, Dynavax Technologies, Yelp, or Honest Company? PR Newswire
04.08.22 - PR Newswire
Dynavax Reports Second Quarter 2022 Financial Results
Dynavax Reports Second Quarter 2022 Financial Results PR Newswire
21.07.22 - PR Newswire
Dynavax to Report Second Quarter Financial Results and Host Conference Call on August 4, 2022
Dynavax to Report Second Quarter Financial Results and Host Conference Call on August 4, 2022 PR Newswire
03.06.22 - Der Aktionär
BioNTech, Moderna, Dynavax & Co: Neue Impfkampagne in Sicht – jetzt zugreifen?
25.05.22 - PR Newswire
Dynavax to Present at the William Blair 42nd Annual Growth Stock Conference
Dynavax to Present at the William Blair 42nd Annual Growth Stock Conference PR Newswire
16.05.22 - PR Newswire
Dynavax to Present at the H.C. Wainwright Global Investment Conference
Dynavax to Present at the H.C. Wainwright Global Investment Conference PR Newswire
12.05.22 - PR Newswire
Independence Realty Trust Set to Join S&P MidCap 400; Alpha and Omega Semiconductor & Dynavax Technologies to Join S&P SmallCap 600
Independence Realty Trust Set to Join S&P MidCap 400; Alpha and Omega Semiconductor & Dynavax Technologies to Join S&P SmallCap 600 PR Newswire
05.05.22 - PR Newswire
Dynavax Reports First Quarter 2022 Financial Results
Dynavax Reports First Quarter 2022 Financial Results PR Newswire
21.04.22 - PR Newswire
Dynavax to Report First Quarter 2022 Financial Results and Host Conference Call on May 5, 2022
Dynavax to Report First Quarter 2022 Financial Results and Host Conference Call on May 5, 2022 PR Newswire
05.04.22 - PR Newswire
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Newssuche

Videos

newspaper
03.05.24 -13,45%
Technical Trading: Gold freitags Long
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »